CRDL vs. VBV, CUS, AIM, FRX, APM, IPA, ITH, GXE, GPH, and MDNA
Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), International Tower Hill Mines (ITH), Gear Energy (GXE), Graphite One (GPH), and Medicenna Therapeutics (MDNA). These companies are all part of the "pharmaceutical products" industry.
Cardiol Therapeutics vs.
Cardiol Therapeutics (TSE:CRDL) and VBI Vaccines (TSE:VBV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, community ranking, risk and analyst recommendations.
VBI Vaccines' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.
11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Given VBI Vaccines' higher probable upside, analysts clearly believe VBI Vaccines is more favorable than Cardiol Therapeutics.
Cardiol Therapeutics has higher earnings, but lower revenue than VBI Vaccines. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than VBI Vaccines, indicating that it is currently the more affordable of the two stocks.
VBI Vaccines received 42 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. Likewise, 70.83% of users gave VBI Vaccines an outperform vote while only 69.23% of users gave Cardiol Therapeutics an outperform vote.
In the previous week, Cardiol Therapeutics had 1 more articles in the media than VBI Vaccines. MarketBeat recorded 1 mentions for Cardiol Therapeutics and 0 mentions for VBI Vaccines. Cardiol Therapeutics' average media sentiment score of 1.11 beat VBI Vaccines' score of 0.00 indicating that Cardiol Therapeutics is being referred to more favorably in the media.
Summary
Cardiol Therapeutics beats VBI Vaccines on 9 of the 15 factors compared between the two stocks.
Get Cardiol Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardiol Therapeutics Competitors List
Related Companies and Tools
This page (TSE:CRDL) was last updated on 1/18/2025 by MarketBeat.com Staff
